0001236031-17-000011.txt : 20170725 0001236031-17-000011.hdr.sgml : 20170725 20170725153511 ACCESSION NUMBER: 0001236031-17-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170724 FILED AS OF DATE: 20170725 DATE AS OF CHANGE: 20170725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PRICHEP PATRICIA B CENTRAL INDEX KEY: 0001236215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 17980387 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-07-24 0 0000725363 CEL SCI CORP cvm 0001236215 PRICHEP PATRICIA B 0 1 0 0 Senior Vice President Convertible Note 2.29 2017-07-24 4 A 0 10917 25000 A 2017-07-24 2017-12-22 Common Stock 10917 41505 D Series NN Warrant 2.52 2017-07-24 4 A 0 10917 0.01 A 2017-07-24 2022-07-24 Common Stock 10917 52422 D Ms. Prichep participated in an offering and purchased a note in the principal amount of $25,000, as well as the Series NN warrant. Shares issuable upon the conversion of the note or the exercise of the warrant will be restricted securities unless registered. Patricia Prichep 2017-07-25